+467.0%
MRNA vs NTRA
+92.9%
+374.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NTRA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.9% | +4.5% | +4.7% |
| 7D | -1.1% | +0.2% | -1.3% | -1.3% |
| 30D | +126.1% | +4.1% | +122.0% | +123.4% |
| 3M | +190.0% | +50.0% | +140.0% | +150.4% |
| 6M | +157.2% | +67.3% | +89.9% | +108.9% |
| YTD | +388.2% | +43.6% | +344.6% | +329.8% |
| 1Y | +467.0% | +89.2% | +377.8% | +342.3% |
| All | +467.0% | +92.9% | +374.1% | +342.3% |
Cumulative growth
Daily Returns
Daily percentage return beside NTRA.
Daily Out/Under-Performance
Portfolio return minus NTRA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTRA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NTRA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling